Outset Medical Inc (OM) Stock Price, Quote & News

Latest News on OM

Mar 18, 2025, 8:30 AM EDT - 22 days ago

Outset Medical Announces One-for-Fifteen Reverse Stock Split

Feb 24, 2025, 4:03 PM EST - 6 weeks ago

Outset Medical to Present at the 45th Annual TD Cowen Health Care Conference

Feb 19, 2025, 8:54 PM EST - 6 weeks ago

Outset Medical, Inc. (OM) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 4:03 PM EST - 6 weeks ago

Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 13, 2025, 4:35 PM EST - 7 weeks ago

Outset Medical Announces Resolution of Warning Letter

Feb 6, 2025, 5:52 PM EST - 2 months ago

Kuehn Law Encourages Investors of Outset Medical, Inc. to Contact Law Firm

Feb 3, 2025, 9:00 AM EST - 2 months ago

Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025

Jan 6, 2025, 8:30 AM EST - 3 months ago

Outset Medical Announces $169 Million Private Placement Financing From Leading Mutual Funds and Healthcare Institutional Investors

Nov 15, 2024, 9:00 AM EST - 5 months ago

Outset Medical to Present at the 2024 Stifel Healthcare Conference

Nov 7, 2024, 9:28 AM EST - 5 months ago

Outset Medical Inc. (OM) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:02 PM EST - 5 months ago

Outset Medical Reports Third Quarter 2024 Financial Results

Oct 23, 2024, 4:05 PM EDT - 5 months ago

New Research Highlights Improvements in Quality of Life and Caregiver Experience for Home Hemodialysis Patients Using Tablo

Oct 23, 2024, 9:00 AM EDT - 6 months ago

Outset Medical to Report Third Quarter 2024 Financial Results on Wednesday, November 6, 2024

Oct 22, 2024, 11:00 AM EDT - 6 months ago

Outset Medical Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Oct 20, 2024, 11:00 AM EDT - 6 months ago

Outset Medical Inc Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm

Oct 18, 2024, 11:00 AM EDT - 6 months ago

Outset Medical Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 17, 2024, 12:45 PM EDT - 6 months ago

Outset Medical (OM) Faces Delisting Threat Amidst Regulatory Woes and Investor Lawsuit - Hagens Berman

Oct 16, 2024, 6:56 PM EDT - 6 months ago

Outset Medical (OM) Shares Down 94% Since Disclosing FDA Warning Letter, Morgan Stanley And JPMorgan Chase Unload Most Of Their Positions In OM Shares - Hagens Berman

Oct 16, 2024, 12:04 PM EDT - 6 months ago

Investors in Outset Medical, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights – OM

Oct 14, 2024, 11:00 AM EDT - 6 months ago

Outset Medical Inc Is Being Sued For Violating Securities Laws And Affected Shareholders Are Urged To Help The Schall Law Firm

Oct 11, 2024, 11:00 AM EDT - 6 months ago

The Schall Law Firm Encourages Investor Participation In A Case Against Outset Medical, Inc.

Oct 10, 2024, 11:00 AM EDT - 6 months ago

Outset Medical Inc Is Being Sued For Possible Securities Fraud And Impacted Shareholders Are Urged To Contact The Schall Law Firm

$The Schall Law Firm Encourages Investor Participation In A Case Against Outset Medical, Inc. For Securities Related Infractions$

Oct 9, 2024, 11:00 AM EDT - 6 months ago

The Schall Law Firm Encourages Investor Participation In A Case Against Outset Medical, Inc. For Securities Related Infractions

Oct 8, 2024, 11:00 AM EDT - 6 months ago

Outset Medical Inc Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm

Oct 6, 2024, 11:00 AM EDT - 6 months ago

Outset Medical Inc Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Urged To Help The Schall Law Firm

Oct 4, 2024, 7:55 PM EDT - 6 months ago

Market Cap	43.68M
Revenue (ttm)	113.69M
Net Income (ttm)	-127.98M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-112.57%
Debt to Equity Ratio	7.36

Volume	248,100
Avg Vol	82,897
Day's Range	N/A - N/A
Shares Out	3.60M
Stochastic %K	65%
Beta	1.91
Analysts	Sell
Price Target	$31.49